Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

AP-1 dimers regulate transcription of the p14/p19ARF tumor suppressor gene

Abstract

Evidence is accumulating about the role of individual AP-1 components in cell proliferation and transformation. Notably, Ras-mediated transformation is characterized by the upregulation of particular AP-1 members, such as c-Jun and Fra-1. The p14/p19ARF tumor suppressor gene is a key link between oncogenic Ras signaling and the p53 pathway. We explored the involvement of AP-1 dimers in the transcriptional regulation of the p14/p19ARF gene. We demonstrate that both the human and mouse ARF promoters are transcriptional targets of selective AP-1 dimers. The ARF promoter is regulated specifically by AP-1 heterodimers containing Fra-1. Overexpression of c-Junāˆ¼Fra-1 dimers in primary murine fibroblast cells led to the upregulation of the endogenous ARF protein and growth arrest. Conversely, inhibition of c-Jun or Fra-1 protein levels resulted in decreased ARF expression. In addition, we show that AP-1 dimers cooperate with oncogenic Ras in the transcriptional activation of the p14/p19ARF promoter. Thus, AP-1 heterodimers may contribute to the regulation of ARF expression upon oncogenic signaling.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Ameyar M, Atfi A, Cai Z, Stancou R, Shatrov V, Bettaieb A and Chouaib S . (1998). J. Biol. Chem., 273, 29002ā€“29008.

  • Ameyar M, Wisniewska M and Weitzman JB . (2003). Biochimie, 85, 747ā€“752.

  • Angel P and Karin M . (1991). Biochim. Biophys. Acta, 1072, 129ā€“157.

  • Bakiri L, Lallemand D, Bossy-Wetzel E and Yaniv M . (2000). EMBO J., 19, 2056ā€“2068.

  • Bakiri L, Matsuo K, Wisniewska M, Wagner EF and Yaniv M . (2002). Mol. Cell. Biol., 22, 4952ā€“4964.

  • Bates S, Phillips AC, Clark PA, Stott F, Peters G, Ludwig RL and Vousden KH . (1998). Nature, 395, 124ā€“125.

  • Behrens A, Jochum W, Sibilia M and Wagner EF . (2000). Oncogene, 19, 2657ā€“2663.

  • Berkovich E, Lamed Y and Ginsberg D . (2003). Cell. Cycle, 2, 127ā€“133.

  • Bos JL, Wolthuis RM, Zwartkruis F and Moen TC . (1989). Cancer Res., 49, 4682ā€“4689.

  • Brookes S, Rowe J, Ruas M, Llanos S, Clark PA, Lomax M, James MC, Vatcheva R, Bates S, Vousden KH, Parry D, Gruis N, Smit N, Bergman W and Peters G . (2002). EMBO J., 21, 2936ā€“2945.

  • Dignam JD, Lebovitz RM and Roeder RG . (1983). Nucleic Acids Res., 11, 1475ā€“1489.

  • Drayton S, Rowe J, Jones R, Vatcheva R, Cuthbert-Heavens D, Marshall J, Fried M and Peters G . (2003). Cancer Cell, 4, 301ā€“310.

  • Eferl R, Ricci R, Kenner L, Zenz R, David JP, Rath M and Wagner EF . (2003). Cell, 112, 181ā€“192.

  • Fleischmann A, Jochum W, Eferl R, Witowsky J and Wagner EF . (2003). Cancer Cell, 4, 477ā€“482.

  • Inoue K, Roussel MF and Sherr CJ . (1999). Proc. Natl. Acad. Sci. USA, 96, 3993ā€“3998.

  • Itahana K, Bhat KP, Jin A, Itahana Y, Hawke D, Kobayashi R and Zhang Y . (2003). Mol. Cell, 12, 1151ā€“1164.

  • Jacobs JJ, Kieboom K, Marino S, DePinho RA and van Lohuizen M . (1999). Nature, 397, 164ā€“168.

  • Jochum W, David JP, Elliott C, Wutz A, Plenk Jr H, Matsuo K and Wagner EF . (2000). Nat. Med., 6, 980ā€“984.

  • Jochum W, Passegue E and Wagner EF . (2001). Oncogene, 20, 2401ā€“2412.

  • Johnson R, Spiegelman B, Hanahan D and Wisdom R . (1996). Mol. Cell. Biol., 16, 4504ā€“4511.

  • Kamijo T, Weber JD, Zambetti G, Zindy F, Roussel MF and Sherr CJ . (1998). Proc. Natl. Acad. Sci. USA, 95, 8292ā€“8297.

  • Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G and Sherr CJ . (1997). Cell, 91, 649ā€“659.

  • Korgaonkar C, Zhao L, Modestou M and Quelle DE . (2002). Mol. Cell. Biol., 22, 196ā€“206.

  • Krimpenfort P, Quon KC, Mooi WJ, Loonstra A and Berns A . (2001). Nature, 413, 83ā€“86.

  • Kuo ML, Duncavage EJ, Mathew R, den Besten W, Pei D, Naeve D, Yamamoto T, Cheng C, Sherr CJ and Roussel MF . (2003). Cancer Res., 63, 1046ā€“1053.

  • Lallemand D, Spyrou G, Yaniv M and Pfarr CM . (1997). Oncogene, 14, 819ā€“830.

  • Llanos S, Clark PA, Rowe J and Peters G . (2001). Nat. Cell Biol., 3, 445ā€“452.

  • Lowe SW and Sherr CJ . (2003). Curr. Opin. Genet. Dev., 13, 77ā€“83.

  • Maestro R, Dei Tos AP, Hamamori Y, Krasnokutsky S, Sartorelli V, Kedes L, Doglioni C, Beach DH and Hannon GJ . (1999). Genes Dev., 13, 2207ā€“2217.

  • Mechta F, Lallemand D, Pfarr CM and Yaniv M . (1997). Oncogene, 14, 837ā€“847.

  • Mechta-Grigoriou F, Gerald D and Yaniv M . (2001). Oncogene, 20, 2378ā€“2389.

  • Modestou M, Puig-Antich V, Korgaonkar C, Eapen A and Quelle DE . (2001). Cancer Res., 61, 3145ā€“3150.

  • Palmero I, Murga M, Zubiaga A and Serrano M . (2002). Oncogene, 21, 2939ā€“2947.

  • Palmero I, Pantoja C and Serrano M . (1998). Nature, 395, 125ā€“126.

  • Pantoja C and Serrano M . (1999). Oncogene, 18, 4974ā€“4982.

  • Parisi T, Pollice A, Di Cristofano A, Calabro V, La Mantia G, Karayan L, Riou JF, Seite P, Migeon J, Cantereau A, Larsen CJ, Dimri GP, Itahana K, Acosta M and Campisi J . (2002). Biochem. Biophys. Res. Commun., 291, 1138ā€“1145.

  • Passegue E and Wagner EF . (2000). EMBO J., 19, 2969ā€“2979.

  • Pfarr CM, Mechta F, Spyrou G, Lallemand D, Carillo S and Yaniv M . (1994). Cell, 76, 747ā€“760.

  • Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon-Cardo C and DePinho RA . (1998). Cell, 92, 713ā€“723.

  • Quelle DE, Zindy F, Ashmun RA and Sherr CJ . (1995). Cell, 83, 993ā€“1000.

  • Ries S, Biederer C, Woods D, Shifman O, Shirasawa S, Sasazuki T, McMahon M, Oren M and McCormick F . (2000). Cell, 103, 321ā€“330.

  • Robertson KD and Jones PA . (1998). Mol. Cell. Biol., 18, 6457ā€“6473.

  • Rocha S, Campbell KJ and Perkins ND . (2003). Mol. Cell, 12, 15ā€“25.

  • Rowland BD, Denissov SG, Douma S, Stunnenberg HG, Bernards R and Peeper DS . (2002). Cancer Cell, 2, 55ā€“65.

  • Schutte J, Minna JD and Birrer MJ . (1989). Proc. Natl. Acad. Sci. USA, 86, 2257ā€“2261.

  • Serrano M . (2000). Carcinogenesis, 21, 865ā€“869.

  • Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D and DePinho RA . (1996). Cell, 85, 27ā€“37.

  • Sharpless NE, Bardeesy N, Lee KH, Carrasco D, Castrillon DH, Aguirre AJ, Wu EA, Horner JW and DePinho RA . (2001). Nature, 413, 86ā€“91.

  • Shaulian E, Schreiber M, Piu F, Beeche M, Wagner EF and Karin M . (2000). Cell, 103, 897ā€“907.

  • Sherr CJ . (2001). Nat. Rev. Mol. Cell. Biol., 2, 731ā€“737.

  • Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden KH and Peters G . (1998). EMBO J., 17, 5001ā€“5014.

  • Sugimoto M, Kuo ML, Roussel MF and Sherr CJ . (2003). Mol. Cell, 11, 415ā€“424.

  • Szabowski A, Maas-Szabowski N, Andrecht S, Kolbus A, Schorpp-Kistner M, Fusenig NE and Angel P . (2000). Cell, 103, 745ā€“755.

  • Tao W and Levine AJ . (1999). Proc. Natl. Acad. Sci. USA, 96, 6937ā€“6941.

  • Thierry F, Heard JM, Dartmann K and Yaniv M . (1987). J. Virol., 61, 134ā€“142.

  • Vallone D, Battista S, Pierantoni GM, Fedele M, Casalino L, Santoro M, Viglietto G, Fusco A and Verde P . (1997). EMBO J., 16, 5310ā€“5321.

  • van Dam H and Castellazzi M . (2001). Oncogene, 20, 2453ā€“2464.

  • Weber JD, Jeffers JR, Rehg JE, Randle DH, Lozano G, Roussel MF, Sherr CJ and Zambetti GP . (2000). Genes Dev., 14, 2358ā€“2365.

  • Weber JD, Taylor LJ, Roussel MF, Sherr CJ and Bar-Sagi D . (1999). Nat. Cell Biol., 1, 20ā€“26.

  • Weitzman JB, Fiette L, Matsuo K and Yaniv M . (2000). Mol. Cell, 6, 1109ā€“1119.

  • Young MR, Nair R, Bucheimer N, Tulsian P, Brown N, Chapp C, Hsu TC and Colburn NH . (2002). Mol. Cell. Biol., 22, 587ā€“598.

Download references

Acknowledgements

We are grateful to P Jones, C Sherr, D Ginsberg and G Langsley for providing reagents. We thank M Pontoglio, S Ait-Si-Ali and L Casalino for helpful discussions and advice. This work was supported by grants from the EC Biomed and Training and Mobility Programs, the Pasteur-Weizmann Foundation and the Association for International Cancer Research (AICR). MAZ was supported by the Ligue contre le Cancer, the Pasteur Institute and AICR. MW was supported by La Fondation pour la Recherche MĆ©dicale (FRM). LB was supported by an EMBO fellowship.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jonathan B Weitzman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ameyar-Zazoua, M., Wisniewska, M., Bakiri, L. et al. AP-1 dimers regulate transcription of the p14/p19ARF tumor suppressor gene. Oncogene 24, 2298ā€“2306 (2005). https://doi.org/10.1038/sj.onc.1208424

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208424

Keywords

This article is cited by

Search

Quick links